Optical catheter sheds light on heart rejection status
This article was originally published in Clinica
Executive Summary
Canada's Biomax Technologies has developed a catheter-based system for monitoring organ rejection after heart transplantation, which the company claims can produce results in seconds and will eliminate the need for biopsies and costly pathological evaluation.